查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600660

连续血糖监测系统市场：按组件、人口统计、患者类型、最终用户、分销管道 - 2025-2030 年全球预测

Continuous Glucose Monitoring Systems Market by Component (Integrated Insulin Pumps, Sensors, Transmitters & Receivers), Demographics (Adult Population, Children Population), Patient Type, End User, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年连续血糖监测系统市场规模为55.4亿美元，预计2024年将达62.1亿美元，2030年将达到125.5亿美元，复合年增长率为12.37%。

连续血糖监测（CGM）系统是一种用于连续追踪糖尿病患者间质液中血糖浓度的设备。这些系统通常由插入皮下的小型感测器、发送资料的发射器以及用于监控的接收器或相容智慧型装置组成。 CGM 的主要需求源自于其提供即时血糖测量、提醒使用者血糖波动以及促进糖尿病管理的能力。 CGM 的应用包括监测第 1 型和第 2 型糖尿病患者的血糖值，以避免低血糖或高血糖。最终用途范围广泛，包括医疗机构、门诊病人机构以及用于糖尿病管理和预防保健的居家照护。

主要市场统计
基准年[2023] 55.4亿美元
预测年份 [2024] 62.1亿美元
预测年份 [2030] 125.5亿美元
复合年增长率（%） 12.37%

CGM 系统的市场成长主要是由于糖尿病盛行率的增加、对先进诊断的认识和接受程度的提高以及对预防性医疗保健的日益重视而推动的。与智慧型装置和穿戴式装置整合、提高感测器精度和舒适度等技术创新代表了市场扩张的重大机会。企业可以透过投资研发来利用这些机会，以提高设备精度、降低成本并改善使用者体验。然而，市场成长面临高成本、某些地区报销有限以及监管障碍等挑战。扩充性问题和频繁校准的需要也是限制采用的因素。

CGM 市场提供了技术创新的机会，包括开拓非侵入性监测系统、增强个人化健康见解的资料分析能力以及整合人工智慧来预测血糖趋势等。与数位健康平台科技巨头的合作也将是有益的。儘管市场前景广阔，但该市场需要技术检验、解决负担能力问题以实现更广泛的获取，并强调教育以改善慢性病管理。总体而言，持续血糖监测技术的不断进步和对数位医疗解决方案的利好政策可以将市场推向新的高度，并改善糖尿病患者的生活品质。

市场动态：快速发展的连续血糖监测系统市场的关键市场洞察

供需的动态交互作用正在改变连续血糖监测系统市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球糖尿病患者数量不断增加
    • CGM 系统的监管批准增加
    • 家庭医疗保健中 CGM 系统的采用率提高
  • 市场限制因素
    • CGM 设备副作用的发生与准确性限制
  • 市场机会
    • 技术进步和 CGM 系统意识的提高
    • 对非侵入性方法和潜在未确诊患者群体的偏好日益增加
  • 市场挑战
    • 报销和严格的监管问题

波特五力：引领连续血糖监测系统市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解连续血糖监测系统市场的外部影响

外部宏观环境因素在塑造连续血糖监测系统市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解连续血糖监测系统市场的竞争格局

连续血糖监测系统市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵连续血糖监测系统市场供应商的绩效评估

FPNV 定位矩阵是评估连续血糖监测系统市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。四个象限清楚且准确地划分了供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球糖尿病患者数量不断增加
      • 增加对 CGM 系统的监管核准
      • 提高 CGM 系统在家庭医疗保健中的采用率
    • 抑制因素
      • CGM 设备副作用的发生与准确性限制
    • 机会
      • 技术进步和 CGM 系统意识的提高
      • 对非侵入性治疗方法和潜在未确诊患者群体的偏好日益增加
    • 任务
      • 报销和严格的监管问题
  • 市场区隔分析
    • 组件：提高 CGM 系统中发送器和接收器的利用率，以实现即时血糖监测
    • 人口统计：儿科 CGM 系统的持续进步使其更有效且侵入性更小
    • 患者类型：CGM 系统在第 1 型糖尿病患者中的重要性日益增加。高精度、最小延迟时间以及针对快速血糖值变化的预测警报
    • 最终用户：具有远端资料共用功能的CGM系统越来越受到家庭患者的青睐
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境
  • 客户客製化

第六章连续血糖监测系统市场：依组成部分

  • 集成胰岛素泵
  • 感应器
  • 发送器和接收器

第七章按人口统计的连续血糖监测系统市场

  • 成年人口
  • 儿童人口

第八章连续血糖监测系统市场（依病患类型）

  • 1型糖尿病
  • 2型糖尿病

第九章连续血糖监测系统市场：依最终用户分类

  • 诊断中心和诊所
  • 家庭保健
  • 加护病房

第10章连续血糖监测系统市场：按分销管道

  • 向机构投资者出售
  • 零售

第十一章美洲连续血糖监测系统市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太连续血糖监测系统市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲/中东/非洲连续血糖监测系统市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Civionix 的 GS1 连续血糖监测系统获得 CE 标誌
    • Dexcom 针对美国人推出新的 CGM，针对不使用胰岛素的糖尿病患者
    • 美国FDA核准Abbott 的 Freestyle Libre 2 和 Freestyle Libre 3 感测器与自动胰岛素给药系统集成

公司名单

  • NXP Semiconductors NV
  • Senseonics Holdings Inc.
  • Nemaura Medical Inc.
  • Sibionics
  • Insulet Corporation
  • Abbott Laboratories
  • AgaMatrix Inc. by I-Sens Inc.
  • Ascensia Diabetes Care Holdings AG
  • Novo Nordisk A/S
  • Ypsomed Holding AG
  • STMicroelectronics NV
  • Johnson & Johnson Services, Inc.
  • Tandem Diabetes Care, Inc.
  • F. Hoffmann-La Roche Ltd.
  • A. Menarini Diagnostics srl
  • Dexcom, Inc.
  • Medtrum Technologies Inc.
  • Texas Instruments Incorporated
  • Medtronic PLC
Product Code: MRR-43676CF422F8

The Continuous Glucose Monitoring Systems Market was valued at USD 5.54 billion in 2023, expected to reach USD 6.21 billion in 2024, and is projected to grow at a CAGR of 12.37%, to USD 12.55 billion by 2030.

Continuous Glucose Monitoring (CGM) systems are devices used to track glucose levels in the interstitial fluid of diabetes patients continuously. These systems typically consist of a small sensor inserted under the skin, a transmitter that sends data, and a receiver or a compatible smart device for monitoring. The primary necessity for CGM stems from its capability to provide real-time glucose readings, alert users about glucose fluctuations, and ease the management of diabetes. The applications of CGM include monitoring blood glucose levels in Type 1 and Type 2 diabetes patients to avoid hypoglycemic or hyperglycemic events. End-use scopes are wide, encompassing healthcare settings, outpatient settings, and home care for diabetes management and preventive care.

KEY MARKET STATISTICS
Base Year [2023] USD 5.54 billion
Estimated Year [2024] USD 6.21 billion
Forecast Year [2030] USD 12.55 billion
CAGR (%) 12.37%

Market growth for CGM systems is significantly driven by the increasing prevalence of diabetes, rising awareness and acceptance of advanced diagnostics, and a growing emphasis on preventive healthcare. Technological innovations such as integration with smart devices and wearables, as well as improvements in sensor accuracy and comfort, present substantial opportunities for market expansion. Companies can capitalize on these opportunities by investing in R&D to enhance device accuracy, reduce costs, and improve user experience. However, market growth faces challenges like high costs, limited insurance reimbursement in certain regions, and regulatory hurdles. Scalability issues and the need for frequent calibration can also limit widespread adoption.

The CGM market presents opportunities for innovation, particularly in developing non-invasive monitoring systems, enhancing data analytics capabilities for personalized health insights, and integrating artificial intelligence to predict glucose trends. Partnerships with tech giants for digital health platforms could also be beneficial. Despite its promising landscape, the market requires navigating technical validation, addressing affordability issues for broader access, and emphasizing education to improve chronic disease management. Overall, continuous advancements in CGM technology and favorable policies towards digital healthcare solutions can propel the market into new dimensions, offering enhanced quality of life for diabetes patients.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Continuous Glucose Monitoring Systems Market

The Continuous Glucose Monitoring Systems Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing Number of Incidence of Diabetic Patients Globally
    • Growing Regulatory Approvals for the CGM Systems
    • Growing Adoption Rate of CGM Systems in Home Healthcare
  • Market Restraints
    • Occurrence of Adverse Effects and Limited Accuracy of CGM Devices
  • Market Opportunities
    • Technological Advancements and Increased Awareness of CGM Systems
    • Rising Preferences for Non-invasive Methods and Potential Undiagnosed Patient Population
  • Market Challenges
    • Reimbursement and Stringent Regulatory Issues

Porter's Five Forces: A Strategic Tool for Navigating the Continuous Glucose Monitoring Systems Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Continuous Glucose Monitoring Systems Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Continuous Glucose Monitoring Systems Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Continuous Glucose Monitoring Systems Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Continuous Glucose Monitoring Systems Market

A detailed market share analysis in the Continuous Glucose Monitoring Systems Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Continuous Glucose Monitoring Systems Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Continuous Glucose Monitoring Systems Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Continuous Glucose Monitoring Systems Market, highlighting leading vendors and their innovative profiles. These include NXP Semiconductors N.V., Senseonics Holdings Inc., Nemaura Medical Inc., Sibionics, Insulet Corporation, Abbott Laboratories, AgaMatrix Inc. by I-Sens Inc., Ascensia Diabetes Care Holdings AG, Novo Nordisk A/S, Ypsomed Holding AG, STMicroelectronics N.V., Johnson & Johnson Services, Inc., Tandem Diabetes Care, Inc., F. Hoffmann-La Roche Ltd., A. Menarini Diagnostics s.r.l, Dexcom, Inc., Medtrum Technologies Inc., Texas Instruments Incorporated, and Medtronic PLC.

Market Segmentation & Coverage

This research report categorizes the Continuous Glucose Monitoring Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Component, market is studied across Integrated Insulin Pumps, Sensors, and Transmitters & Receivers.
  • Based on Demographics, market is studied across Adult Population and Children Population.
  • Based on Patient Type, market is studied across Type 1 Diabetes and Type 2 Diabetes.
  • Based on End User, market is studied across Diagnostic Centers & Clinics, Home Healthcare, and ICUs.
  • Based on Distribution Channel, market is studied across Institutional Sales and Retail Sales.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Number of Incidence of Diabetic Patients Globally
      • 5.1.1.2. Growing Regulatory Approvals for the CGM Systems
      • 5.1.1.3. Growing Adoption Rate of CGM Systems in Home Healthcare
    • 5.1.2. Restraints
      • 5.1.2.1. Occurrence of Adverse Effects and Limited Accuracy of CGM Devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological Advancements and Increased Awareness of CGM Systems
      • 5.1.3.2. Rising Preferences for Non-invasive Methods and Potential Undiagnosed Patient Population
    • 5.1.4. Challenges
      • 5.1.4.1. Reimbursement and Stringent Regulatory Issues
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Increasing utilization of transmitters & receivers in CGM systems for real-time glucose monitoring
    • 5.2.2. Demographics: Ongoing advancements in children CGM systems to make it more effective and less invasive
    • 5.2.3. Patient Type: Rising significance of CGM system in Type 1 diabetes patient for high accuracy, minimal lag time, and predictive alerts for rapid glucose changes
    • 5.2.4. End User: Growing preference of CGM systems by home patients with remote data sharing capabilities
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Continuous Glucose Monitoring Systems Market, by Component

  • 6.1. Introduction
  • 6.2. Integrated Insulin Pumps
  • 6.3. Sensors
  • 6.4. Transmitters & Receivers

7. Continuous Glucose Monitoring Systems Market, by Demographics

  • 7.1. Introduction
  • 7.2. Adult Population
  • 7.3. Children Population

8. Continuous Glucose Monitoring Systems Market, by Patient Type

  • 8.1. Introduction
  • 8.2. Type 1 Diabetes
  • 8.3. Type 2 Diabetes

9. Continuous Glucose Monitoring Systems Market, by End User

  • 9.1. Introduction
  • 9.2. Diagnostic Centers & Clinics
  • 9.3. Home Healthcare
  • 9.4. ICUs

10. Continuous Glucose Monitoring Systems Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Institutional Sales
  • 10.3. Retail Sales

11. Americas Continuous Glucose Monitoring Systems Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Continuous Glucose Monitoring Systems Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Continuous Glucose Monitoring Systems Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Sibionics obtains CE Mark for GS1 continuous glucose monitoring system
    • 14.3.2. Dexcom targets Americans with new CGM aimed at non-insulin-using diabetics
    • 14.3.3. U.S. FDA Clears Abbott's Freestyle Libre 2 and Freestyle Libre 3 Sensors for Integration with Automated Insulin Delivery Systems

Companies Mentioned

  • 1. NXP Semiconductors N.V.
  • 2. Senseonics Holdings Inc.
  • 3. Nemaura Medical Inc.
  • 4. Sibionics
  • 5. Insulet Corporation
  • 6. Abbott Laboratories
  • 7. AgaMatrix Inc. by I-Sens Inc.
  • 8. Ascensia Diabetes Care Holdings AG
  • 9. Novo Nordisk A/S
  • 10. Ypsomed Holding AG
  • 11. STMicroelectronics N.V.
  • 12. Johnson & Johnson Services, Inc.
  • 13. Tandem Diabetes Care, Inc.
  • 14. F. Hoffmann-La Roche Ltd.
  • 15. A. Menarini Diagnostics s.r.l
  • 16. Dexcom, Inc.
  • 17. Medtrum Technologies Inc.
  • 18. Texas Instruments Incorporated
  • 19. Medtronic PLC

LIST OF FIGURES

  • FIGURE 1. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET RESEARCH PROCESS
  • FIGURE 2. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET DYNAMICS
  • TABLE 7. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INTEGRATED INSULIN PUMPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY SENSORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TRANSMITTERS & RECEIVERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ADULT POPULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY CHILDREN POPULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DIAGNOSTIC CENTERS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY ICUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY INSTITUTIONAL SALES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY RETAIL SALES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 36. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 40. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 68. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 73. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 78. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 83. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 87. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 88. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 93. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 98. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 102. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 103. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 108. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 113. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 118. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 128. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 129. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 134. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 139. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 144. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 148. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 149. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. ISRAEL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 154. ISRAEL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 159. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 163. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 164. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 168. NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 169. NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 173. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 174. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. POLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 179. POLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. QATAR CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 184. QATAR CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 188. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 189. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 193. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 194. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 198. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 199. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 203. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 204. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 208. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 209. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 213. SWITZERLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 214. SWITZERLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 218. TURKEY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 219. TURKEY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DEMOGRAPHICS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 233. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 234. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023